$16.35
-0.3-1.77%
Pre-Market: 5:21 PM EDT
15 minutes delayed
Comments
Loading...
Prothena Corp (PRTA) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestProthena Corp (NASDAQ:PRTA) Stock Quotes, Forecast and News Summary
Prothena Corp Stock (NASDAQ: PRTA) stock price, news, charts, stock research, profile.
Compare
EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS better than industry
FAQ
How do I buy Prothena Corp (PRTA) stock?
You can purchase shares of Prothena Corp (NASDAQ:PRTA) through any online brokerage.
Who are Prothena Corp (PRTA) competitors?
Other companies in Prothena Corp’s space includes: Immunome (NASDAQ:IMNM), Gyre Therapeutics (NASDAQ:GYRE), Replimune Group (NASDAQ:REPL), Arcutis Biotherapeutics (NASDAQ:ARQT) and Tango Therapeutics (NASDAQ:TNGX).
What is the forecast, or price target, for Prothena Corp (PRTA) stock?
Prothena Corp has a consensus price target of $66.90.
What is the current price for Prothena Corp (PRTA)?
The stock price for Prothena Corp (NASDAQ: PRTA) is $16.3547 last updated October 1, 2024 at 5:21 PM EDT.
Does Prothena Corp (PRTA) pay a dividend?
There are no upcoming dividends for Prothena Corp.
When is Prothena Corp (NASDAQ:PRTA) reporting earnings?
Prothena Corp’s Q3 earnings are confirmed for Thursday, October 31, 2024.
Is Prothena Corp (PRTA) going to split?
There is no upcoming split for Prothena Corp.
What sector and industry does Prothena Corp (PRTA) operate in?
Prothena Corp is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.